Commentary on "Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism": A new role for plasminogen activator inhibitor-1-An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
- PMID: 35754015
- PMCID: PMC9328391
- DOI: 10.1111/jth.15728
Commentary on "Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism": A new role for plasminogen activator inhibitor-1-An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
Conflict of interest statement
There are no conflicts of interest reported by the author.
Comment on
-
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.J Thromb Haemost. 2022 Jul;20(7):1618-1626. doi: 10.1111/jth.15701. Epub 2022 Mar 25. J Thromb Haemost. 2022. PMID: 35289062 Free PMC article.
References
-
- Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep‐vein thrombosis in adults. Thromb Haemost. 2012;108:1097‐1108. - PubMed
-
- ISTH Steering Committee for World Thrombosis Day . Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014;12:1580‐1590. - PubMed
-
- Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. ‘The study of men born in 1913'. Arch Intern Med. 1997;157:1665‐1670. - PubMed
-
- Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25‐year population‐based study. Arch Intern Med. 1998;158:585‐593. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
